Ectopic expression of guanylyl cyclase C in CD34+ progenitor cells in peripheral blood

Journal of Clinical Oncology

Volumn 19, Issue 19, 2001, Pages 3951-3959

  Fava, T A ^a   Desnoyers, R ^a   Schulz, S ^a   Park, J ^a   Weinberg, D ^a   Mitchell, E ^a   Waldman, S A ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANYLATE CYCLASE;

ARTICLE; CANCER CELL; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; METASTASIS; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035478543     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.19.3951     Document Type: Article

References (58)

1. Disease-free survival and recurrence after resection of colorectal carcinoma
2. Screening for colorectal cancer
3. Colonoscopy after curative resection of colorectal cancer
4. Cancer statistics, 1990
5. Colon cancer overview
6. Epidemiology of cancer in the United States
7. The National Cancer Data Base: Report on colon cancer
8. Screening and early cancer detection
9. Goals of screening
10. Use of guanylyl cyclase C for detecting micrometastases in lymph nodes of patients with colon cancer
11. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer
12. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction
13. Epithelial tumour cell detection and the unsolved problems of nested RT-PCR: A new sensitive one step method without false positive results
14. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination
15. Minimal illegitimate levels of cytokeratin K19 expression in mononucleated blood cells detected by a reverse transcription PCR method (RT-PCR)
16. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients
17. Keratin gene expression in non-epithelial tissues: Detection with polymerase chain reaction
18. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction
19. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors
20. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes
21. Escherichia coli cytotoxins and enterotoxins
22. The localization of guanylate cyclase in rat small intestinal epithelium
23. Binding of E coli heat-stable enterotoxin to rat intestinal brush borders and to basolateral membranes
24. Ligand-based histochemical localization and capture of cells expressing heat-stable enterotoxin receptors
25. Activation of intestinal guanylate cyclase by heat-stable enterotoxin of Escherichia coli: Studies of tissue specificity, potential receptors, and intermediates
26. Escherichia coli heat-stable toxin receptors in human colonic tumors
27. Distribution of membrane bound guanylyl cyclases in human intestine
28. Age-related differences in receptors for Escherichia coli heat-stable enterotoxin in the small and large intestine of children
29. Small and large intestinal guanylate cyclase activity in children: Effect of age and stimulation by Escherichia coli heat-stable enterotoxin
30. Mechanism of action of Escherichia coli heat stable enterotoxin in a human colonic cell line
31. T84 cell receptor binding and guanyl cyclase activation by Escherichia coli heat-stable toxin
32. Receptors for Escherichia coli heat stable enterotoxin in human intestine and in a human intestinal cell line (Caco-2)
33. Comparison of receptors for Escherichia coli heat-stable enterotoxin: Novel receptor present in IEC- 6 cells
34. Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues
35. Escherichia coli heat-stable enterotoxin receptors: A novel marker for colorectal tumors
36. CK20 gene expression: Technical limits for the detection of circulating tumor cells
37. Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients: Correlation with pathological stage
38. Hemopoiesis in healthy old people and centenarians: Well-maintained responsiveness of CD34+ cells to hemopoietic growth factors and remodeling of cytokine network
39. Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both
40. Cost of patient follow-up after potentially curative colorectal cancer treatment
41. Outcomes after detection of metastatic carcinoma of the colon and rectum in a national hospital system
42. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer
43. Local recurrence of colorectal cancer: Effect of early detection and aggressive surgery
44. Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma?
45. Postoperative evaluation of patients with colorectal cancer
46. Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients
47. Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity
48. Illegitimate transcription: Transcription of any gene in any cell type
49. Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: Implications for the detection of hematogenous prostate cells and standardization
50. Illegitimate transcription: Its use for studying genetic abnormalities in lymphoblastoid cells from patients with Glanzmann thrombasthenia
51. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow
52. Are tissues a patch quilt of ectopic gene expression?
53. Ectopic (illegitimate) transcription: New possibilities for the analysis and diagnosis of human genetic disease
54. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer
55. Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer
56. Carcinoembryonic antigen and recurrent colorectal cancer
57. A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma
58. Heterogeneity of guanylyl cyclase C expressed by human colorectal cancer cell lines in vitro